News

Home > News

"Fifteenth China Listed Company Value Evaluation" was Released

2021/9/29 20:29:44 Views:248


On September 28, 2021, the " Fifteenth China Listed Company Value Evaluation " list sponsored by Securities Times and co-organized by Caitong Securities was announced. There are a number of in vitro diagnosis companies were listed.


The purpose of this selection is to choose a group of companies that play a leading role in the capital market, including 100 listed companies on the Main Board, 50 listed companies on the ChiNext Board, and 10 listed companies on the SSE STAR Market.



Top 100 listed companies by value on the main board

Autobio

Kingmed

Livzon


Top 100 listed companies by value on the ChiNext Board

Mindray

Wondfo

Hybribio

BGI

Amoydx

Wuxi AppTech


Top 10 listed companies by value on the SSE STAR Market

Bioperfectus

Lifotronic


IPO Star Award

Sansure

Gongdong

Wantai


Social Responsibility Award of China Listed Companies

Mindray

Kingmed

Livzon


Top 50 Listed companies for growth

Da An Gene


Outstanding Board Secretary award for IPO Operation

Snibe: Zhang Lei


Outstanding ChiNext Board Secretary award

Mindray: Li Wenmei

Wondfo: Hu Hong

Sinocare: Huang Anguo

Edan: Zu Youdong

Hybribio: Chen Yi


The Securities Times launched the selection activity in May this year, mainly to the high-quality development of the capital market, support listed companies to enhance their competitiveness. The selection activity adheres to the principles of fairness, impartiality and openness, promotes the concept of value investment, and adheres to legal and compliant corporate governance standards. The selection is based on the overall performance of listed companies in creating wealth for investors, shareholders and themselves during the selection period and the past two years.